Peak6 Investments LLC Alnylam Pharmaceuticals, Inc. Transaction History

Peak6 Investments LLC

  • $37.5 Billion
  • Q2 2024

A detailed history of Peak6 Investments LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 8,400 shares of ALNY stock, worth $2.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,400
Previous 2,500 236.0%
Holding current value
$2.31 Million
Previous $373,000 447.18%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$143.31 - $247.0 $790,927 - $1.36 Million
-5,519 Reduced 67.33%
2,678 $650,000
Q1 2024

May 14, 2024
BUY
$146.51 - $198.2 $489,050 - $661,591
3,338 Added 68.7%
8,197 $1.23 Million
Q4 2023

Feb 13, 2024
SELL
$151.41 - $196.57 $1.25 Million - $1.62 Million
-8,253 Reduced 62.94%
4,859 $930,000
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $809,962 - $1 Million
4,743 Added 56.67%
13,112 $2.32 Million
Q2 2023

Aug 11, 2023
BUY
$185.01 - $212.05 $294,350 - $337,371
1,591 Added 23.47%
8,369 $1.59 Million
Q1 2023

May 12, 2023
BUY
$182.66 - $235.53 $632,916 - $816,111
3,465 Added 104.59%
6,778 $1.36 Million
Q4 2022

Feb 10, 2023
SELL
$185.53 - $241.31 $451,023 - $586,624
-2,431 Reduced 42.32%
3,313 $788,000
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $795,773 - $1.33 Million
5,744 New
5,744 $1.15 Million
Q4 2021

Feb 11, 2022
BUY
$159.56 - $209.29 $750,570 - $984,500
4,704 New
4,704 $798,000
Q3 2021

Nov 12, 2021
SELL
$169.75 - $207.73 $2.52 Million - $3.08 Million
-14,820 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$128.63 - $176.89 $1.9 Million - $2.61 Million
-14,751 Reduced 49.88%
14,820 $2.51 Million
Q4 2020

Feb 12, 2021
BUY
$122.97 - $147.0 $2.14 Million - $2.56 Million
17,438 Added 143.72%
29,571 $3.84 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $2.47 Million - $3.38 Million
-20,396 Reduced 62.7%
12,133 $1.77 Million
Q2 2020

Aug 14, 2020
SELL
$104.21 - $156.44 $539,912 - $810,515
-5,181 Reduced 13.74%
32,529 $4.82 Million
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $3.36 Million - $4.83 Million
36,056 Added 2179.93%
37,710 $4.11 Million
Q4 2019

Feb 13, 2020
SELL
$74.51 - $124.23 $1.83 Million - $3.05 Million
-24,577 Reduced 93.69%
1,654 $190,000
Q3 2019

Nov 08, 2019
BUY
$70.9 - $87.82 $1.48 Million - $1.83 Million
20,861 Added 388.47%
26,231 $2.11 Million
Q2 2019

Aug 14, 2019
BUY
$65.86 - $92.79 $353,668 - $498,282
5,370 New
5,370 $390,000

Others Institutions Holding ALNY

# of Institutions
614
Shares Held
108M
Call Options Held
2.33M
Put Options Held
2.17M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email